Nicodemus Kristin K, Law Amanda J, Radulescu Eugenia, Luna Augustin, Kolachana Bhaskar, Vakkalanka Radhakrishna, Rujescu Dan, Giegling Ina, Straub Richard E, McGee Kate, Gold Bert, Dean Michael, Muglia Pierandrea, Callicott Joseph H, Tan Hao-Yang, Weinberger Daniel R
Genes, Cognition, and Psychosis Program, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Arch Gen Psychiatry. 2010 Oct;67(10):991-1001. doi: 10.1001/archgenpsychiatry.2010.117.
NRG1 is a schizophrenia candidate gene and plays an important role in brain development and neural function. Schizophrenia is a complex disorder, with etiology likely due to epistasis.
To examine epistasis between NRG1 and selected N-methyl-d-aspartate-glutamate pathway partners implicated in its effects, including ERBB4, AKT1, DLG4, NOS1, and NOS1AP.
Schizophrenia case-control sample analyzed using machine learning algorithms and logistic regression with follow-up using neuroimaging on an independent sample of healthy controls.
A referred sample of schizophrenic patients (n = 296) meeting DSM-IV criteria for schizophrenia spectrum disorder and a volunteer sample of controls for case-control comparison (n = 365) and a separate volunteer sample of controls for neuroimaging (n = 172).
Epistatic association between single-nucleotide polymorphisms (SNPs) and case-control status; epistatic association between SNPs and the blood oxygen level-dependent physiological response during working memory measured by functional magnetic resonance imaging.
We observed interaction between NRG1 5' and 3' SNPs rs4560751 and rs3802160 (likelihood ratio test P = .00020) and schizophrenia, which was validated using functional magnetic resonance imaging of working memory in healthy controls; carriers of risk-associated genotypes showed inefficient processing in the dorsolateral prefrontal cortex (P = .015, familywise error corrected). We observed epistasis between NRG1 (rs10503929; Thr286/289/294Met) and its receptor ERBB4 (rs1026882; likelihood ratio test P = .035); a 3-way interaction with these 2 SNPs and AKT1 (rs2494734) was also observed (odds ratio, 27.13; 95% confidence interval, 3.30-223.03; likelihood ratio test P = .042). These same 2- and 3-way interactions were further biologically validated via functional magnetic resonance imaging: healthy individuals carrying risk genotypes for NRG1 and ERBB4, or these 2 together with AKT1, were disproportionately less efficient in dorsolateral prefrontal cortex processing. Lower-level interactions were not observed between NRG1 /ERBB4 and AKT1 in association or neuroimaging, consistent with biological evidence that NRG1 × ERBB4 interaction modulates downstream AKT1 signaling.
Our data suggest complex epistatic effects implicating an NRG1 molecular pathway in cognitive brain function and the pathogenesis of schizophrenia.
神经调节蛋白1(NRG1)是一个与精神分裂症相关的候选基因,在大脑发育和神经功能中发挥重要作用。精神分裂症是一种复杂的疾病,其病因可能是基因上位效应。
研究NRG1与选定的参与其作用的N-甲基-D-天冬氨酸-谷氨酸途径伙伴之间的上位效应,这些伙伴包括表皮生长因子受体4(ERBB4)、蛋白激酶B(AKT1)、突触后致密蛋白95(DLG4)、一氧化氮合酶1(NOS1)和一氧化氮合酶1关联蛋白(NOS1AP)。
使用机器学习算法和逻辑回归分析精神分裂症病例对照样本,并对独立的健康对照样本进行神经影像学随访。
符合精神分裂症谱系障碍DSM-IV标准的转诊精神分裂症患者样本(n = 296),用于病例对照比较的对照志愿者样本(n = 365),以及用于神经影像学研究的单独对照志愿者样本(n = 172)。
单核苷酸多态性(SNP)与病例对照状态之间的上位关联;SNP与功能磁共振成像测量的工作记忆期间血氧水平依赖的生理反应之间的上位关联。
我们观察到NRG1 5'和3' SNP rs4560751和rs3802160之间的相互作用(似然比检验P = 0.00020)与精神分裂症相关,这在健康对照的工作记忆功能磁共振成像中得到验证;风险相关基因型携带者在背外侧前额叶皮层的处理效率低下(P = 0.015,经家族性错误校正)。我们观察到NRG1(rs10503929;苏氨酸286/289/294甲硫氨酸)与其受体ERBB4(rs1026882;似然比检验P = 0.035)之间的上位效应;还观察到这两个SNP与AKT1(rs2494734)之间的三向相互作用(优势比,27.13;95%置信区间,3.30 - 223.03;似然比检验P = 0.042)。通过功能磁共振成像进一步对这些相同的双向和三向相互作用进行生物学验证:携带NRG1和ERBB4风险基因型或这两者与AKT1一起的健康个体,在背外侧前额叶皮层处理中效率明显较低。在关联分析或神经影像学研究中未观察到NRG1 /ERBB4与AKT1之间较低水平的相互作用,这与NRG1×ERBB4相互作用调节下游AKT1信号传导的生物学证据一致。
我们的数据表明,复杂的上位效应涉及NRG1分子途径在认知脑功能和精神分裂症发病机制中的作用。